Phentermine

Clare Lee, M.D., MHS, Stacy Elder, Pharm.D., BCP, Reza Alavi, M.D.
Phentermine is a topic covered in the Johns Hopkins Diabetes Guide.

To view the entire topic, please or .

Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:

-- The first section of this topic is shown below --

INDICATIONS

FDA

  • Adult and pediatric patients older than 16 years of age for short-term management of obesity (adjunct to weight reduction program of exercise, behavioral modification and caloric restriction) in patients with an initial BMI ≥ 30 kg/m2, or BMI ≥ 27 kg/m2 in the presence of other risk factors (e.g., hypertension, diabetes, hyperlipidemia).

-- To view the remaining sections of this topic, please or --

INDICATIONS

FDA

  • Adult and pediatric patients older than 16 years of age for short-term management of obesity (adjunct to weight reduction program of exercise, behavioral modification and caloric restriction) in patients with an initial BMI ≥ 30 kg/m2, or BMI ≥ 27 kg/m2 in the presence of other risk factors (e.g., hypertension, diabetes, hyperlipidemia).

There's more to see -- the rest of this topic is available only to subscribers.

Last updated: February 2, 2022